Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib

Detalles Bibliográficos
Autores principales: Pinard, Camille, Mignard, Claire, Samain, Agnès, Duval-Modeste, Anne-Bénédicte, Joly, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728437/
https://www.ncbi.nlm.nih.gov/pubmed/29296640
http://dx.doi.org/10.1016/j.jdcr.2017.06.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728437/
https://www.ncbi.nlm.nih.gov/pubmed/29296640
http://dx.doi.org/10.1016/j.jdcr.2017.06.027

Ejemplares similares